HomeMarketsSharesNissan Motor Co., Ltd.

Trade Nissan Motor Co., Ltd. - 7201 CFD

Market is not available at the momentMarket information is presented
as of 2026-10-06T02:26:07+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.68
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
¥1,000
Overnight funding adjustment
Charges from full value of position
-0.014438 %
(-¥3)

Trade size with leverage ~ ¥20,000

Money from leverage ~ $¥19,000


-0.01444%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
¥1,000
Overnight funding adjustment
Charges from full value of position
-0.007784 %
(-¥2)

Trade size with leverage ~ ¥20,000

Money from leverage ~ $¥19,000


-0.00778%
Overnight funding adjustment time21:00 (UTC)
CurrencyJPY
Min traded quantity10
Margin5.00%
Stock exchangeJapan
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close281.91
Open282.41
1-Year Change-20.84%
Day's Range279.42 - 287.41

Trade Nissan Motor Co., Ltd. - 7201

About Nissan Motor Co Ltd

NISSAN MOTOR CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of automobiles and parts, as well as the provision of sales financial services. The Company operates through two business segments. The Automotive segment is engaged in the manufacture and sale of electric vehicles, compact cars, light cars, minivans, commercial vehicles, trucks, micro buses and other automobiles, as well as related parts. The Sales Finance segment is engaged in the sales finance business and the leasing business to support sales activities of automobile business.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Nissan Motor Co Ltd revenues increased 16% to Y6.154T. Net income totaled Y201.34B vs. loss of Y367.72B. Revenues reflect Automobile segment increase of 18% to Y5.39T, Sales Financing segment increase of 3% to Y763.92B, Northern America segment increase of 18% to Y2.926T, Other segment increase of 67% to Y627.18B, Europe segment increase of 14% to Y709.49B.

Equity composition

Up to FY'02 B-WAS & all D-WAS were estemated. FY'5-'07 1&3Q:WAS=O/S(estimated). FY'94 Fnls NA. FY'08 Q3 BWAS=O/S, DWAS was estimated. FY'08 Q1's DWAS was estimated, o/s=WAS.

Latest shares articles

BNP Paribas stock forecast
BNP Paribas stock forecast: Q2 earnings beat estimates
BNP Paribas is a French banking group whose recent developments include a Swift ledger transaction with HSBC for Siemens and continued focus on eurozone interest rates. Explore third-party BNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago
Boeing stock forecast
Boeing stock forecast: FAA investigates Miami freighter crash
Boeing is a US aerospace manufacturer whose shares remain in focus after a 767-300 freighter crash in Miami prompted an FAA investigation. Explore third-party BA price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago
CaixaBank stock forecast
CaixaBank stock forecast: BPI exits Angola market
CaixaBank is a Spanish bank whose Portuguese unit, Banco BPI, agreed to sell its 33.35% stake in Banco de Fomento de Angola for €388.5m. Explore third-party CABK price targets and technical analysis. Past performance is not a reliable indicator of future results.
15 hours ago
Valneva stock forecast
Valneva stock forecast: EMA validates Lyme vaccine application
Valneva is a French vaccine company listed on Euronext Paris. In August, the EMA validated the marketing-authorisation application for its Lyme disease vaccine candidate with Pfizer. Explore third-party VLA price targets. Past performance is not a reliable indicator of future results.
19 hours ago

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready